TotalMarketCap

Chemomab Therapeutics

CMMBNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.302 M

$1.28 +4.07%

Close of 6 Nov 2026

As of 6 Nov 2026, Chemomab Therapeutics (CMMB) has a market capitalization of $10.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$8.99M

Loss-making

Shares outstanding

575,381,320

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #412BiovieBIVI$10.5M
  2. #413CytoMed TherapeuticsGDTC$10.4M
  3. #414Chemomab TherapeuticsCMMB$10.3M
  4. #415Azora Therapeutics, Inc. (DE)AZR$10.0M
  5. #416Rocket OneRKTO$10.0M

What if Chemomab Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,508,290

Per share 2,740,851× higher

Bitcoin $1.53T

$189,827.46

Per share 148,303× higher

Apple $5.02T

$623,185.82

Per share 486,864× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Chemomab Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.